CTS has been used to treat heart failure for over 200 years through its inotropic effect due to partial inhibition of Na/K-ATPase induced intracellular Na+ change coupled with increases in intracellular calcium (Ca2+) through Na+/Ca2+ exchanger (NCX). Here, SLC8A1 is linked to heart failure.